SYNLOGIC, INC. Increase (Decrease) in Deferred Liabilities
SYNLOGIC, INC. (SYBX) reported Increase (Decrease) in Deferred Liabilities of $1.27 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2020-03-12
- SYNLOGIC, INC. increase (decrease) in deferred liabilities for the quarter ending 2018-12-31 was -$90.00K.
- SYNLOGIC, INC. increase (decrease) in deferred liabilities for the quarter ending 2018-09-30 was $269.00K.
- SYNLOGIC, INC. increase (decrease) in deferred liabilities for the quarter ending 2018-06-30 was $800.00K.
- SYNLOGIC, INC. increase (decrease) in deferred liabilities for the quarter ending 2018-03-31 was $295.00K.
- SYNLOGIC, INC. increase (decrease) in deferred liabilities for fiscal 2018 was $1.27M.
- SYNLOGIC, INC. increase (decrease) in deferred liabilities for fiscal 2017 was -$1.12M, a 5438.10% decline from fiscal 2016.
- SYNLOGIC, INC. increase (decrease) in deferred liabilities for fiscal 2016 was $21.00K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $179.00K derived: sum of 2 quarters · filed 2020-03-12 | $979.00K derived: sum of 3 quarters · filed 2020-03-12 | $1.27M 10-K · filed 2020-03-12 |
| 2018-09-30 | $269.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.07M derived: sum of 2 quarters · filed 2019-11-12 | $1.36M 10-Q · filed 2019-11-12 | $781.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.09M 10-Q · filed 2019-08-08 | $512.00K derived: sum of 3 quarters · filed 2019-08-08 | $101.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $295.00K 10-Q · filed 2019-05-09 | -$288.00K derived: sum of 2 quarters · filed 2019-05-09 | -$699.00K derived: sum of 3 quarters · filed 2019-05-09 | -$763.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$994.00K derived: sum of 2 quarters · filed 2019-03-12 | -$1.06M derived: sum of 3 quarters · filed 2019-03-12 | -$1.12M 10-K · filed 2019-03-12 |
| 2017-09-30 | -$411.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$475.00K derived: sum of 2 quarters · filed 2018-11-13 | -$538.00K 10-Q · filed 2018-11-13 | -$594.00K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | -$64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$127.00K 10-Q · filed 2018-08-09 | -$183.00K derived: sum of 3 quarters · filed 2018-08-09 | |
| 2017-03-31 | -$63.00K 10-Q · filed 2018-05-15 | -$119.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | -$56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $21.00K 10-K · filed 2018-03-20 | ||
| 2016-09-30 | $77.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |